調査レポート | • レポートコード：GIR-2104Z05243 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、エストロゲン＆プロゲステロンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。エストロゲン＆プロゲステロンの種類別市場規模（アグレプリストン、ミフェプリストン、アソプリスニル、テラプリストン、ウリプリスタル酢酸）、用途別市場規模（薬局、病院、内分泌科）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・エストロゲン＆プロゲステロンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Gedeon Richter Plc.、Bayer Oy、N.V.Organon、Pfizer Healthcare Ireland、Jenapharm GmbH & Co. KG、Besins Healthcare Benelux、MERCK SERONO LIMITED、Abbott Healthcare Products B.V.、Teva Pharma - Produtos Farmaceuticos,Lda.、Aspen Pharmacare Australia Pty Ltd.、Dr.Kade Pharmazeutische Fabrik GmbH、F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A.、Eli Lilly Nederland B.V、Orion Corporation、AstraZeneca UK Limited、Novartis Pharma Schweiz AG ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：アグレプリストン、ミフェプリストン、アソプリスニル、テラプリストン、ウリプリスタル酢酸 ・用途別分析2016年-2026年：薬局、病院、内分泌科 ・エストロゲン＆プロゲステロンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・エストロゲン＆プロゲステロンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・エストロゲン＆プロゲステロンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・エストロゲン＆プロゲステロンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・エストロゲン＆プロゲステロンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Estrogen and Progesterone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Estrogen and Progesterone size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Estrogen and Progesterone market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Estrogen and Progesterone market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Aglepristone
Mifepristone
Asoprisnil
Telapristone
Ulipristal Acetate
Market segment by Application can be divided into
Pharmacy
Hospital
Department of Endocrinology
The key market players for global Estrogen and Progesterone market are listed below:
Gedeon Richter Plc.
Bayer Oy
N.V.Organon
Pfizer Healthcare Ireland
Jenapharm GmbH & Co. KG
Besins Healthcare Benelux
MERCK SERONO LIMITED
Abbott Healthcare Products B.V.
Teva Pharma – Produtos Farmaceuticos,Lda.
Aspen Pharmacare Australia Pty Ltd.
Dr.Kade Pharmazeutische Fabrik GmbH
F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A.
Eli Lilly Nederland B.V
Orion Corporation
AstraZeneca UK Limited
Novartis Pharma Schweiz AG
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Estrogen and Progesterone Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Estrogen and Progesterone Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Aglepristone
1.2.3 Mifepristone
1.2.4 Asoprisnil
1.2.5 Telapristone
1.2.6 Ulipristal Acetate
1.3 Market Analysis by Application
1.3.1 Overview: Global Estrogen and Progesterone Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Pharmacy
1.3.3 Hospital
1.3.4 Department of Endocrinology
1.4 Global Estrogen and Progesterone Market Size & Forecast
1.4.1 Global Estrogen and Progesterone Sales in Value (2016-2026))
1.4.2 Global Estrogen and Progesterone Sales in Volume (2016-2026)
1.4.3 Global Estrogen and Progesterone Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Estrogen and Progesterone Production Capacity Analysis
1.5.1 Global Estrogen and Progesterone Total Production Capacity (2016-2026)
1.5.2 Global Estrogen and Progesterone Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Estrogen and Progesterone Market Drivers
1.6.2 Estrogen and Progesterone Market Restraints
1.6.3 Estrogen and Progesterone Trends Analysis
2 Manufacturers Profiles
2.1 Gedeon Richter Plc.
2.1.1 Gedeon Richter Plc. Details
2.1.2 Gedeon Richter Plc. Major Business
2.1.3 Gedeon Richter Plc. Estrogen and Progesterone Product and Services
2.1.4 Gedeon Richter Plc. Estrogen and Progesterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Bayer Oy
2.2.1 Bayer Oy Details
2.2.2 Bayer Oy Major Business
2.2.3 Bayer Oy Estrogen and Progesterone Product and Services
2.2.4 Bayer Oy Estrogen and Progesterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 N.V.Organon
2.3.1 N.V.Organon Details
2.3.2 N.V.Organon Major Business
2.3.3 N.V.Organon Estrogen and Progesterone Product and Services
2.3.4 N.V.Organon Estrogen and Progesterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Pfizer Healthcare Ireland
2.4.1 Pfizer Healthcare Ireland Details
2.4.2 Pfizer Healthcare Ireland Major Business
2.4.3 Pfizer Healthcare Ireland Estrogen and Progesterone Product and Services
2.4.4 Pfizer Healthcare Ireland Estrogen and Progesterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Jenapharm GmbH & Co. KG
2.5.1 Jenapharm GmbH & Co. KG Details
2.5.2 Jenapharm GmbH & Co. KG Major Business
2.5.3 Jenapharm GmbH & Co. KG Estrogen and Progesterone Product and Services
2.5.4 Jenapharm GmbH & Co. KG Estrogen and Progesterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Besins Healthcare Benelux
2.6.1 Besins Healthcare Benelux Details
2.6.2 Besins Healthcare Benelux Major Business
2.6.3 Besins Healthcare Benelux Estrogen and Progesterone Product and Services
2.6.4 Besins Healthcare Benelux Estrogen and Progesterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 MERCK SERONO LIMITED
2.7.1 MERCK SERONO LIMITED Details
2.7.2 MERCK SERONO LIMITED Major Business
2.7.3 MERCK SERONO LIMITED Estrogen and Progesterone Product and Services
2.7.4 MERCK SERONO LIMITED Estrogen and Progesterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Abbott Healthcare Products B.V.
2.8.1 Abbott Healthcare Products B.V. Details
2.8.2 Abbott Healthcare Products B.V. Major Business
2.8.3 Abbott Healthcare Products B.V. Estrogen and Progesterone Product and Services
2.8.4 Abbott Healthcare Products B.V. Estrogen and Progesterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Teva Pharma – Produtos Farmaceuticos,Lda.
2.9.1 Teva Pharma – Produtos Farmaceuticos,Lda. Details
2.9.2 Teva Pharma – Produtos Farmaceuticos,Lda. Major Business
2.9.3 Teva Pharma – Produtos Farmaceuticos,Lda. Estrogen and Progesterone Product and Services
2.9.4 Teva Pharma – Produtos Farmaceuticos,Lda. Estrogen and Progesterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Aspen Pharmacare Australia Pty Ltd.
2.10.1 Aspen Pharmacare Australia Pty Ltd. Details
2.10.2 Aspen Pharmacare Australia Pty Ltd. Major Business
2.10.3 Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Product and Services
2.10.4 Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Dr.Kade Pharmazeutische Fabrik GmbH
2.11.1 Dr.Kade Pharmazeutische Fabrik GmbH Details
2.11.2 Dr.Kade Pharmazeutische Fabrik GmbH Major Business
2.11.3 Dr.Kade Pharmazeutische Fabrik GmbH Estrogen and Progesterone Product and Services
2.11.4 Dr.Kade Pharmazeutische Fabrik GmbH Estrogen and Progesterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A.
2.12.1 F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Details
2.12.2 F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Major Business
2.12.3 F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Estrogen and Progesterone Product and Services
2.12.4 F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Estrogen and Progesterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Eli Lilly Nederland B.V
2.13.1 Eli Lilly Nederland B.V Details
2.13.2 Eli Lilly Nederland B.V Major Business
2.13.3 Eli Lilly Nederland B.V Estrogen and Progesterone Product and Services
2.13.4 Eli Lilly Nederland B.V Estrogen and Progesterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Orion Corporation
2.14.1 Orion Corporation Details
2.14.2 Orion Corporation Major Business
2.14.3 Orion Corporation Estrogen and Progesterone Product and Services
2.14.4 Orion Corporation Estrogen and Progesterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 AstraZeneca UK Limited
2.15.1 AstraZeneca UK Limited Details
2.15.2 AstraZeneca UK Limited Major Business
2.15.3 AstraZeneca UK Limited Estrogen and Progesterone Product and Services
2.15.4 AstraZeneca UK Limited Estrogen and Progesterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Novartis Pharma Schweiz AG
2.16.1 Novartis Pharma Schweiz AG Details
2.16.2 Novartis Pharma Schweiz AG Major Business
2.16.3 Novartis Pharma Schweiz AG Estrogen and Progesterone Product and Services
2.16.4 Novartis Pharma Schweiz AG Estrogen and Progesterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Estrogen and Progesterone Sales by Manufacturer
3.1 Global Estrogen and Progesterone Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Estrogen and Progesterone Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Estrogen and Progesterone
3.4 Market Concentration Rate
3.4.1 Top 3 Estrogen and Progesterone Manufacturer Market Share
3.4.2 Top 6 Estrogen and Progesterone Manufacturer Market Share
3.5 Global Estrogen and Progesterone Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Estrogen and Progesterone Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Estrogen and Progesterone Market Size by Region
4.1.1 Global Estrogen and Progesterone Sales in Volume by Region (2016-2026)
4.1.2 Global Estrogen and Progesterone Revenue by Region (2016-2026)
4.2 North America Estrogen and Progesterone Revenue (2016-2026)
4.3 Europe Estrogen and Progesterone Revenue (2016-2026)
4.4 Asia-Pacific Estrogen and Progesterone Revenue (2016-2026)
4.5 South America Estrogen and Progesterone Revenue (2016-2026)
4.6 Middle East and Africa Estrogen and Progesterone Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Estrogen and Progesterone Sales in Volume by Type (2016-2026)
5.2 Global Estrogen and Progesterone Revenue by Type (2016-2026)
5.3 Global Estrogen and Progesterone Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Estrogen and Progesterone Sales in Volume by Application (2016-2026)
6.2 Global Estrogen and Progesterone Revenue by Application (2016-2026)
6.3 Global Estrogen and Progesterone Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Estrogen and Progesterone Sales by Type (2016-2026)
7.2 North America Estrogen and Progesterone Sales by Application (2016-2026)
7.3 North America Estrogen and Progesterone Market Size by Country
7.3.1 North America Estrogen and Progesterone Sales in Volume by Country (2016-2026)
7.3.2 North America Estrogen and Progesterone Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Estrogen and Progesterone Sales by Type (2016-2026)
8.2 Europe Estrogen and Progesterone Sales by Application (2016-2026)
8.3 Europe Estrogen and Progesterone Market Size by Country
8.3.1 Europe Estrogen and Progesterone Sales in Volume by Country (2016-2026)
8.3.2 Europe Estrogen and Progesterone Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Estrogen and Progesterone Sales by Type (2016-2026)
9.2 Asia-Pacific Estrogen and Progesterone Sales by Application (2016-2026)
9.3 Asia-Pacific Estrogen and Progesterone Market Size by Region
9.3.1 Asia-Pacific Estrogen and Progesterone Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Estrogen and Progesterone Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Estrogen and Progesterone Sales by Type (2016-2026)
10.2 South America Estrogen and Progesterone Sales by Application (2016-2026)
10.3 South America Estrogen and Progesterone Market Size by Country
10.3.1 South America Estrogen and Progesterone Sales in Volume by Country (2016-2026)
10.3.2 South America Estrogen and Progesterone Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Estrogen and Progesterone Sales by Type (2016-2026)
11.2 Middle East & Africa Estrogen and Progesterone Sales by Application (2016-2026)
11.3 Middle East & Africa Estrogen and Progesterone Market Size by Country
11.3.1 Middle East & Africa Estrogen and Progesterone Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Estrogen and Progesterone Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Estrogen and Progesterone Typical Distributors
12.3 Estrogen and Progesterone Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Estrogen and Progesterone Revenue by Type, (USD Million), 2021-2026
Table 2. Global Estrogen and Progesterone Revenue by Application, (USD Million), 2021-2026
Table 3. Gedeon Richter Plc. Basic Information, Manufacturing Base and Competitors
Table 4. Gedeon Richter Plc. Major Business
Table 5. Gedeon Richter Plc. Estrogen and Progesterone Product and Services
Table 6. Gedeon Richter Plc. Estrogen and Progesterone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bayer Oy Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Oy Major Business
Table 9. Bayer Oy Estrogen and Progesterone Product and Services
Table 10. Bayer Oy Estrogen and Progesterone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. N.V.Organon Basic Information, Manufacturing Base and Competitors
Table 12. N.V.Organon Major Business
Table 13. N.V.Organon Estrogen and Progesterone Product and Services
Table 14. N.V.Organon Estrogen and Progesterone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Pfizer Healthcare Ireland Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Healthcare Ireland Major Business
Table 17. Pfizer Healthcare Ireland Estrogen and Progesterone Product and Services
Table 18. Pfizer Healthcare Ireland Estrogen and Progesterone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Jenapharm GmbH & Co. KG Basic Information, Manufacturing Base and Competitors
Table 20. Jenapharm GmbH & Co. KG Major Business
Table 21. Jenapharm GmbH & Co. KG Estrogen and Progesterone Product and Services
Table 22. Jenapharm GmbH & Co. KG Estrogen and Progesterone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Besins Healthcare Benelux Basic Information, Manufacturing Base and Competitors
Table 24. Besins Healthcare Benelux Major Business
Table 25. Besins Healthcare Benelux Estrogen and Progesterone Product and Services
Table 26. Besins Healthcare Benelux Estrogen and Progesterone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. MERCK SERONO LIMITED Basic Information, Manufacturing Base and Competitors
Table 28. MERCK SERONO LIMITED Major Business
Table 29. MERCK SERONO LIMITED Estrogen and Progesterone Product and Services
Table 30. MERCK SERONO LIMITED Estrogen and Progesterone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Abbott Healthcare Products B.V. Basic Information, Manufacturing Base and Competitors
Table 32. Abbott Healthcare Products B.V. Major Business
Table 33. Abbott Healthcare Products B.V. Estrogen and Progesterone Product and Services
Table 34. Abbott Healthcare Products B.V. Estrogen and Progesterone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Teva Pharma - Produtos Farmaceuticos,Lda. Basic Information, Manufacturing Base and Competitors
Table 36. Teva Pharma - Produtos Farmaceuticos,Lda. Major Business
Table 37. Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Product and Services
Table 38. Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Aspen Pharmacare Australia Pty Ltd. Basic Information, Manufacturing Base and Competitors
Table 40. Aspen Pharmacare Australia Pty Ltd. Major Business
Table 41. Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Product and Services
Table 42. Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Dr.Kade Pharmazeutische Fabrik GmbH Basic Information, Manufacturing Base and Competitors
Table 44. Dr.Kade Pharmazeutische Fabrik GmbH Major Business
Table 45. Dr.Kade Pharmazeutische Fabrik GmbH Estrogen and Progesterone Product and Services
Table 46. Dr.Kade Pharmazeutische Fabrik GmbH Estrogen and Progesterone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Basic Information, Manufacturing Base and Competitors
Table 48. F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Major Business
Table 49. F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Estrogen and Progesterone Product and Services
Table 50. F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Estrogen and Progesterone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Eli Lilly Nederland B.V Basic Information, Manufacturing Base and Competitors
Table 52. Eli Lilly Nederland B.V Major Business
Table 53. Eli Lilly Nederland B.V Estrogen and Progesterone Product and Services
Table 54. Eli Lilly Nederland B.V Estrogen and Progesterone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Orion Corporation Basic Information, Manufacturing Base and Competitors
Table 56. Orion Corporation Major Business
Table 57. Orion Corporation Estrogen and Progesterone Product and Services
Table 58. Orion Corporation Estrogen and Progesterone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. AstraZeneca UK Limited Basic Information, Manufacturing Base and Competitors
Table 60. AstraZeneca UK Limited Major Business
Table 61. AstraZeneca UK Limited Estrogen and Progesterone Product and Services
Table 62. AstraZeneca UK Limited Estrogen and Progesterone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Novartis Pharma Schweiz AG Basic Information, Manufacturing Base and Competitors
Table 64. Novartis Pharma Schweiz AG Major Business
Table 65. Novartis Pharma Schweiz AG Estrogen and Progesterone Product and Services
Table 66. Novartis Pharma Schweiz AG Estrogen and Progesterone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Global Estrogen and Progesterone Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 68. Global Estrogen and Progesterone Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 69. Market Position of Manufacturers in Estrogen and Progesterone, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 70. Global Estrogen and Progesterone Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 71. Head Office and Estrogen and Progesterone Production Site of Key Manufacturer
Table 72. Global Estrogen and Progesterone Sales by Region (2016-2021e) & (K Pcs)
Table 73. Global Estrogen and Progesterone Sales by Region (2021-2026) & (K Pcs)
Table 74. Global Estrogen and Progesterone Revenue by Region (2016-2021e) & (USD Million)
Table 75. Global Estrogen and Progesterone Revenue by Region (2021-2026) & (USD Million)
Table 76. Global Estrogen and Progesterone Sales by Type (2016-2021e) & (K Pcs)
Table 77. Global Estrogen and Progesterone Sales by Type (2021-2026) & (K Pcs)
Table 78. Global Estrogen and Progesterone Revenue by Type (2016-2021e) & (USD Million)
Table 79. Global Estrogen and Progesterone Revenue by Type (2021-2026) & (USD Million)
Table 80. Global Estrogen and Progesterone Price by Type (2016-2021e) & (USD/Pcs)
Table 81. Global Estrogen and Progesterone Price by Type (2021-2026) & (USD/Pcs)
Table 82. Global Estrogen and Progesterone Sales by Application (2016-2021e) & (K Pcs)
Table 83. Global Estrogen and Progesterone Sales by Application (2021-2026) & (K Pcs)
Table 84. Global Estrogen and Progesterone Revenue by Application (2016-2021e) & (USD Million)
Table 85. Global Estrogen and Progesterone Revenue by Application (2021-2026) & (USD Million)
Table 86. Global Estrogen and Progesterone Price by Application (2016-2021e) & (USD/Pcs)
Table 87. Global Estrogen and Progesterone Price by Application (2021-2026) & (USD/Pcs)
Table 88. North America Estrogen and Progesterone Sales by Country (2016-2021e) & (K Pcs)
Table 89. North America Estrogen and Progesterone Sales by Country (2021-2026) & (K Pcs)
Table 90. North America Estrogen and Progesterone Revenue by Country (2016-2021e) & (USD Million)
Table 91. North America Estrogen and Progesterone Revenue by Country (2021-2026) & (USD Million)
Table 92. North America Estrogen and Progesterone Sales by Type (2016-2021e) & (K Pcs)
Table 93. North America Estrogen and Progesterone Sales by Type (2021-2026) & (K Pcs)
Table 94. North America Estrogen and Progesterone Sales by Application (2016-2021e) & (K Pcs)
Table 95. North America Estrogen and Progesterone Sales by Application (2021-2026) & (K Pcs)
Table 96. Europe Estrogen and Progesterone Sales by Country (2016-2021e) & (K Pcs)
Table 97. Europe Estrogen and Progesterone Sales by Country (2021-2026) & (K Pcs)
Table 98. Europe Estrogen and Progesterone Revenue by Country (2016-2021e) & (USD Million)
Table 99. Europe Estrogen and Progesterone Revenue by Country (2021-2026) & (USD Million)
Table 100. Europe Estrogen and Progesterone Sales by Type (2016-2021e) & (K Pcs)
Table 101. Europe Estrogen and Progesterone Sales by Type (2021-2026) & (K Pcs)
Table 102. Europe Estrogen and Progesterone Sales by Application (2016-2021e) & (K Pcs)
Table 103. Europe Estrogen and Progesterone Sales by Application (2021-2026) & (K Pcs)
Table 104. Asia-Pacific Estrogen and Progesterone Sales by Region (2016-2021e) & (K Pcs)
Table 105. Asia-Pacific Estrogen and Progesterone Sales by Region (2021-2026) & (K Pcs)
Table 106. Asia-Pacific Estrogen and Progesterone Revenue by Region (2016-2021e) & (USD Million)
Table 107. Asia-Pacific Estrogen and Progesterone Revenue by Region (2021-2026) & (USD Million)
Table 108. Asia-Pacific Estrogen and Progesterone Sales by Type (2016-2021e) & (K Pcs)
Table 109. Asia-Pacific Estrogen and Progesterone Sales by Type (2021-2026) & (K Pcs)
Table 110. Asia-Pacific Estrogen and Progesterone Sales by Application (2016-2021e) & (K Pcs)
Table 111. Asia-Pacific Estrogen and Progesterone Sales by Application (2021-2026) & (K Pcs)
Table 112. South America Estrogen and Progesterone Sales by Country (2016-2021e) & (K Pcs)
Table 113. South America Estrogen and Progesterone Sales by Country (2021-2026) & (K Pcs)
Table 114. South America Estrogen and Progesterone Revenue by Country (2016-2021e) & (USD Million)
Table 115. South America Estrogen and Progesterone Revenue by Country (2021-2026) & (USD Million)
Table 116. South America Estrogen and Progesterone Sales by Type (2016-2021e) & (K Pcs)
Table 117. South America Estrogen and Progesterone Sales by Type (2021-2026) & (K Pcs)
Table 118. South America Estrogen and Progesterone Sales by Application (2016-2021e) & (K Pcs)
Table 119. South America Estrogen and Progesterone Sales by Application (2021-2026) & (K Pcs)
Table 120. Middle East & Africa Estrogen and Progesterone Sales by Country (2016-2021e) & (K Pcs)
Table 121. Middle East & Africa Estrogen and Progesterone Sales by Country (2021-2026) & (K Pcs)
Table 122. Middle East & Africa Estrogen and Progesterone Revenue by Country (2016-2021e) & (USD Million)
Table 123. Middle East & Africa Estrogen and Progesterone Revenue by Country (2021-2026) & (USD Million)
Table 124. Middle East & Africa Estrogen and Progesterone Sales by Type (2016-2021e) & (K Pcs)
Table 125. Middle East & Africa Estrogen and Progesterone Sales by Type (2021-2026) & (K Pcs)
Table 126. Middle East & Africa Estrogen and Progesterone Sales by Application (2016-2021e) & (K Pcs)
Table 127. Middle East & Africa Estrogen and Progesterone Sales by Application (2021-2026) & (K Pcs)
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Estrogen and Progesterone Typical Distributors
Table 131. Estrogen and Progesterone Typical Customers
List of Figures
Figure 1. Estrogen and Progesterone Picture
Figure 2. Global Estrogen and Progesterone Sales Market Share by Type in 2020
Figure 3. Aglepristone
Figure 4. Mifepristone
Figure 5. Asoprisnil
Figure 6. Telapristone
Figure 7. Ulipristal Acetate
Figure 8. Global Estrogen and Progesterone Sales Market Share by Application in 2020
Figure 9. Pharmacy
Figure 10. Hospital
Figure 11. Department of Endocrinology
Figure 12. Global Estrogen and Progesterone Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 13. Global Estrogen and Progesterone Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Estrogen and Progesterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Estrogen and Progesterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Estrogen and Progesterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Estrogen and Progesterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Estrogen and Progesterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Estrogen and Progesterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Estrogen and Progesterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Estrogen and Progesterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Estrogen and Progesterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Estrogen and Progesterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Estrogen and Progesterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Estrogen and Progesterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Estrogen and Progesterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Estrogen and Progesterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Estrogen and Progesterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Estrogen and Progesterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Estrogen and Progesterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Estrogen and Progesterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Estrogen and Progesterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Estrogen and Progesterone Sales (2016-2026) & (K Pcs)
Figure 34. Global Estrogen and Progesterone Production Capacity (2016-2026) & (K Pcs)
Figure 35. Global Estrogen and Progesterone Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Estrogen and Progesterone Market Drivers
Figure 37. Estrogen and Progesterone Market Restraints
Figure 38. Estrogen and Progesterone Market Trends
Figure 39. Global Estrogen and Progesterone Sales Market Share by Manufacturer in 2020
Figure 40. Global Estrogen and Progesterone Revenue Market Share by Manufacturer in 2020
Figure 41. Estrogen and Progesterone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Estrogen and Progesterone Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Estrogen and Progesterone Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Estrogen and Progesterone Sales Market Share by Region (2016-2026)
Figure 45. Global Estrogen and Progesterone Revenue Market Share by Region (2016-2026)
Figure 46. North America Estrogen and Progesterone Revenue (2016-2026) & (USD Million)
Figure 47. Europe Estrogen and Progesterone Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Estrogen and Progesterone Revenue (2016-2026) & (USD Million)
Figure 49. South America Estrogen and Progesterone Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Estrogen and Progesterone Revenue (2016-2026) & (USD Million)
Figure 51. Global Estrogen and Progesterone Sales Market Share by Type (2016-2026)
Figure 52. Global Estrogen and Progesterone Revenue Market Share by Type (2016-2026)
Figure 53. Global Estrogen and Progesterone Price by Type (2016-2026) & (USD/Pcs)
Figure 54. Global Estrogen and Progesterone Sales Market Share by Application (2016-2026)
Figure 55. Global Estrogen and Progesterone Revenue Market Share by Application (2016-2026)
Figure 56. Global Estrogen and Progesterone Price by Application (2016-2026) & (USD/Pcs)
Figure 57. North America Estrogen and Progesterone Sales Market Share by Country (2016-2026)
Figure 58. North America Estrogen and Progesterone Revenue Market Share by Country (2016-2026)
Figure 59. North America Estrogen and Progesterone Sales Market Share by Type (2016-2026)
Figure 60. North America Estrogen and Progesterone Sales Market Share by Application (2016-2026)
Figure 61. Europe Estrogen and Progesterone Sales Market Share by Country (2016-2026)
Figure 62. Europe Estrogen and Progesterone Revenue Market Share by Country (2016-2026)
Figure 63. Europe Estrogen and Progesterone Sales Market Share by Type (2016-2026)
Figure 64. Europe Estrogen and Progesterone Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Estrogen and Progesterone Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Estrogen and Progesterone Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Estrogen and Progesterone Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Estrogen and Progesterone Sales Market Share by Application (2016-2026)
Figure 69. South America Estrogen and Progesterone Sales Market Share by Country (2016-2026)
Figure 70. South America Estrogen and Progesterone Revenue Market Share by Country (2016-2026)
Figure 71. South America Estrogen and Progesterone Sales Market Share by Type (2016-2026)
Figure 72. South America Estrogen and Progesterone Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Estrogen and Progesterone Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Estrogen and Progesterone Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Estrogen and Progesterone Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Estrogen and Progesterone Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界のプロゲステロンProg市場規模・現状・予測（2021年-2027年） Progesterone is a natural progesterone secreted by the corpus luteum of ovary, which has a significant morphological effect on the endometrium stimulated by estrogen in vivo, and is necessary for maintaining pregnancy.For the treatment of menstrual disorders, such as amenorrhea and functional uterin…- 世界の緊急避妊薬市場 2021：企業別、地域別、種類・用途別 The Emergency Contraceptives market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の生殖ホルモン市場規模・現状・予測（2021年-2027年） Reproductive hormones are usually made in the ovaries (in females) and testes (in males)，which use to helping develop and maintain female and male sex characteristics and play an important role in the menstrual cycle, fertility, and pregnancy. Globally, the reproductive hormone industry market is re…
- 世界の自立救急科市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Freestanding Emergency Department Market The global Freestanding Emergency Department market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high da…
- 世界のトコフェロール酢酸エステル市場 2021：企業別、地域別、種類・用途別 The Tocopherol Acetate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…